QQ客服 官方微博 反馈留言

	Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
	Xiao Yinglian; Zhang Shutian; Dai Ning; Fei Guijun; Goh Khean-Lee; Chun Hoon Jai; Sheu Bor-Shyang; Chong Chui Fung; Funao Nobuo; Zhou Wen
	2019
关键词	erosive oesophagitis gastric acid gastro-oesophageal reflux disease proton pump inhibition
ISSN号	1468-3288
DOI	10.1136/gutjnl-2019-318365
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6338039
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Xiao Yinglian,Zhang Shutian,Dai Ning,et al. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis[J],2019.
APA	Xiao Yinglian.,Zhang Shutian.,Dai Ning.,Fei Guijun.,Goh Khean-Lee.,...&Chen Minhu.(2019).Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis..
MLA	Xiao Yinglian,et al."Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis".(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。